127 related articles for article (PubMed ID: 32432714)
1. Protective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model.
Wurster S; Robinson P; Albert ND; Tarrand JJ; Goff M; Swamydas M; Lim JK; Lionakis MS; Kontoyiannis DP
J Infect Dis; 2020 Aug; 222(6):989-994. PubMed ID: 32432714
[TBL] [Abstract][Full Text] [Related]
2. Chitinase Induction Prior to Caspofungin Treatment of Experimental Invasive Aspergillosis in Neutropenic Rats Does Not Enhance Survival.
Refos JM; Vonk AG; Ten Kate MT; Verbrugh HA; Bakker-Woudenberg IAJM; van de Sande WWJ
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084744
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus fumigatus Transcription Factors Involved in the Caspofungin Paradoxical Effect.
Valero C; Colabardini AC; Chiaratto J; Pardeshi L; de Castro PA; Ferreira Filho JA; Silva LP; Rocha MC; Malavazi I; Costa JH; Fill T; Barros MH; Wong SSW; Aimanianda V; Wong KH; Goldman GH
mBio; 2020 Jun; 11(3):. PubMed ID: 32546620
[No Abstract] [Full Text] [Related]
4. Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis.
Wurster S; Albert ND; Bharadwaj U; Kasembeli MM; Tarrand JJ; Daver N; Kontoyiannis DP
Front Immunol; 2022; 13():838344. PubMed ID: 35251033
[TBL] [Abstract][Full Text] [Related]
5. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
Pérez-Pitarch A; Ferriols-Lisart R; Aguilar G; Ezquer-Garín C; Belda FJ; Guglieri-López B
Int J Antimicrob Agents; 2018 Jan; 51(1):115-121. PubMed ID: 28666752
[TBL] [Abstract][Full Text] [Related]
6. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Schaufele RL; Francesconi A; Bacher J; Avila NA; Walsh TJ
Antimicrob Agents Chemother; 2002 Jan; 46(1):12-23. PubMed ID: 11751105
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of the Orotomides against
Hope WW; McEntee L; Livermore J; Whalley S; Johnson A; Farrington N; Kolamunnage-Dona R; Schwartz J; Kennedy A; Law D; Birch M; Rex JH
mBio; 2017 Aug; 8(4):. PubMed ID: 28830945
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice.
Abruzzo GK; Gill CJ; Flattery AM; Kong L; Leighton C; Smith JG; Pikounis VB; Bartizal K; Rosen H
Antimicrob Agents Chemother; 2000 Sep; 44(9):2310-8. PubMed ID: 10952573
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
10. Invasive pulmonary aspergillosis due to Aspergillus lentulus: Successful treatment of a liver transplant patient.
Yoshida H; Seki M; Umeyama T; Urai M; Kinjo Y; Nishi I; Toyokawa M; Kaneko Y; Ohno H; Miyazaki Y; Tomono K
J Infect Chemother; 2015 Jun; 21(6):479-81. PubMed ID: 25828927
[TBL] [Abstract][Full Text] [Related]
11. Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy.
Refos JM; Vonk AG; Ten Kate MT; Eadie K; Verbrugh HA; Bakker-Woudenberg IAJM; van de Sande WWJ
PLoS One; 2017; 12(7):e0180961. PubMed ID: 28742113
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of caspofungin against Aspergillus terreus.
Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Fallani S; Manso E; Pisa E; Giannini D; Novelli A; Cassetta MI; Mazzei T; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Dec; 49(12):5133-5. PubMed ID: 16304185
[TBL] [Abstract][Full Text] [Related]
13. APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.
Gebremariam T; Alkhazraji S; Alqarihi A; Jeon HH; Gu Y; Kapoor M; Shaw KJ; Ibrahim AS
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455236
[TBL] [Abstract][Full Text] [Related]
14. The novel fungal CYP51 inhibitor VT-1598 displays classic dose-dependent antifungal activity in murine models of invasive aspergillosis.
Garvey EP; Sharp AD; Warn PA; Yates CM; Atari M; Thomas S; Schotzinger RJ
Med Mycol; 2020 Jun; 58(4):505-513. PubMed ID: 32476008
[TBL] [Abstract][Full Text] [Related]
15. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.
Bowman JC; Abruzzo GK; Anderson JW; Flattery AM; Gill CJ; Pikounis VB; Schmatz DM; Liberator PA; Douglas CM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3474-81. PubMed ID: 11709327
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin: first approved agent in a new class of antifungals.
Johnson MD; Perfect JR
Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
[TBL] [Abstract][Full Text] [Related]
17. Echinocandin activity against Aspergillus spp. and the importance of pharmacodynamics.
Lewis JS
Med Mycol; 2009; 47 Suppl 1():S376-81. PubMed ID: 19296368
[TBL] [Abstract][Full Text] [Related]
18. Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus.
Tetsuka N; Yaguchi T; Machida H; Ito S; Miyairi I
Pediatr Int; 2017 Mar; 59(3):362-363. PubMed ID: 28317305
[No Abstract] [Full Text] [Related]
19. Blockade Of PD-1 Attenuated Postsepsis Aspergillosis Via The Activation of IFN-γ and The Dampening of IL-10.
Vu CTB; Thammahong A; Yagita H; Azuma M; Hirankarn N; Ritprajak P; Leelahavanichkul A
Shock; 2020 Apr; 53(4):514-524. PubMed ID: 31306346
[TBL] [Abstract][Full Text] [Related]
20. Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
Gebremariam T; Alkhazraji S; Gu Y; Singh S; Alqarihi A; Shaw KJ; Ibrahim AS
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
